Assessing Continuous Glucose Monitors in Healthy Children

Completed · Phase 4

Conditions studied: Diabetes Mellitus

In brief

Continuous glucose monitors may be useful in the treatment of children with Type 1 diabetes mellitus. The purpose of this study was to determine whether two FDA-approved continuous glucose monitors, the Continuous Glucose Monitoring System (CGMS) and the GlucoWatch G2TM Biographer (GW2B), are sufficiently accurate to use in future studies to characterize glucose levels in children.

Key facts

Study ID

NCT00069602

Run by

Jaeb Center for Health Research

People needed

20

Starts

2002-08-01

Expected to finish

2002-11-01

Last updated by the study team

2016-09-05

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Weight >= 16.0 kg (35 lbs)
• Body mass index between the 10th to 90th percentile for age and sex
• HbA1c within normal limits
• Hematocrit within normal limits

You may not qualify if…

• History of diabetes
• History of positive islet cell antibody testing
• Family history of Type 1 or Type 2 diabetes in a sibling or parent
• Medication use of any type in the 7 days prior to study entry
• Skin abnormalities contraindicating device use

Where it is running

• Division of Pediatric Endocrinology and Diabetes, Stanford University — Stanford, California, United States
• Barbara Davis Center for Childhood Diabetes, University of Colorado — Denver, Colorado, United States
• Department of Pediatrics, Yale University School of Medicine — New Haven, Connecticut, United States
• Nemours Children's Clinic — Jacksonville, Florida, United States
• Jaeb Center for Health Research — Tampa, Florida, United States
• Department of Pediatrics, University of Iowa Carver College of Medicine — Iowa City, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.